IVF Clinics Told to Cut Multiple Births to 10%
By BBC,
BBC
| 02. 09. 2012
IVF clinics have been told that no more than 10% of births should be twins or triplets by regulators.
The Human Fertilisation and Embryology Authority (HFEA) set the target in order to cut the number of multiple pregnancies from fertility treatment.
Such pregnancies carry significant risks to mother and babies, and a policy of single embryo transfer was introduced in January 2009.
The new rules come into effect in October this year.
Multiple-birth pregnancies have a higher chance of miscarriage, and of leading to premature birth and of babies with cerebral palsy.
Single embryo transfer (SET) is particularly recommended for women having IVF who are under 37, having their first cycle of treatment, and have "excellent quality" embryos.
Currently, clinics offering fertility treatment have a target of no more than 15%.
Embryologists say clinics are generally achieving that rate, or somewhere near it.
That is down from 23.6% at the beginning of 2008.
Best Chance?
Writing to clinics to announce the latest change, Alan Doran, chief executive of the HFEA, said: "The sector as a whole has responded very...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
